Atlas Trials

A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Clinical trial NCT05658146 · COMPLETED

Trial details

NCT number
NCT05658146
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2023-01-06
Primary completion
2023-07-05
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.